Jeffrey Davis, Director of Regulatory Affairs
- Summary of MAT Issues: The “X Waiver Saga”, ACEP Applauds Bill to Expedite Patient Access to Treatment for Opioid Use Disorder & The New Medicare Payment for MAT Initiated in the ED
- Summary of Financial Relief Options
- Summary of ACEP’s MIPS Value Pathway (MVP) Submitted to CMS
- Summary of MIPS COVID-19 Hardship Exemption
